[The effect of ginkgo biloba on healthy elderly subjects].

A Cieza, P Maier, E Pöppel
{"title":"[The effect of ginkgo biloba on healthy elderly subjects].","authors":"A Cieza,&nbsp;P Maier,&nbsp;E Pöppel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>Over the past 25 years, numerous studies have confirmed the positive effect of the special ginkgo extract EGb 761 on the mental ability and emotional well-being of patients with cognitive disorders of vascular genesis, and Alzheimer-type dementia. The following study investigated the short-term effect of the special ginkgo extract EGb 761 on the subjective emotional well-being of healthy elderly subjects. STUDY POPULATION AND METHOD: The study was designed as a randomized double-blind, monocenter study with parallel groups. It included 66 healthy subjects of both sexes aged between 50 and 65 with no age-related cognitive impairments. For a period of 4 weeks, 34 subjects received a daily dose of 240 mg EGb 761, and 32 a placebo. Prior to starting medication and after 28 days of treatment, subjects completed the following scales and questionnaires to establish subjective emotional well-being: the Profile of Mood States (POMS), the Self Rating Depression Scale (SDS), three Visual Analog Scales to assess the quality of life (VAS-QoL), general health (VAS-GH) and mental health (VAS-MH), and a new instrument for assessing changes in general subjective well-being, the Subjective Intensity Score Mood (SIS Mood). Depending on the underlying distribution of the variables analyzed, parametric (t-tests) or nonparametric tests (U-tests) were performed to compare mean values and distributions both within and between the treatment groups.</p><p><strong>Results: </strong>The final examination revealed a statistically significant difference between the two groups for the VAS mental health and quality of life, as also for SIS Mood at the telephone interview in week 2. A comparison of baseline with the final examination within the groups showed a statistically significant improvement in the EGb 761 group for the variables: depression, fatigue, anger and SDS. For none of the variables investigated was a worsening observed in the EGb 761 group.</p><p><strong>Conclusions: </strong>The results suggest a positive effect of EGb 761 on the subjective emotional well-being of healthy elderly persons.</p>","PeriodicalId":12358,"journal":{"name":"Fortschritte der Medizin. Originalien","volume":"121 1","pages":"5-10"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fortschritte der Medizin. Originalien","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim: Over the past 25 years, numerous studies have confirmed the positive effect of the special ginkgo extract EGb 761 on the mental ability and emotional well-being of patients with cognitive disorders of vascular genesis, and Alzheimer-type dementia. The following study investigated the short-term effect of the special ginkgo extract EGb 761 on the subjective emotional well-being of healthy elderly subjects. STUDY POPULATION AND METHOD: The study was designed as a randomized double-blind, monocenter study with parallel groups. It included 66 healthy subjects of both sexes aged between 50 and 65 with no age-related cognitive impairments. For a period of 4 weeks, 34 subjects received a daily dose of 240 mg EGb 761, and 32 a placebo. Prior to starting medication and after 28 days of treatment, subjects completed the following scales and questionnaires to establish subjective emotional well-being: the Profile of Mood States (POMS), the Self Rating Depression Scale (SDS), three Visual Analog Scales to assess the quality of life (VAS-QoL), general health (VAS-GH) and mental health (VAS-MH), and a new instrument for assessing changes in general subjective well-being, the Subjective Intensity Score Mood (SIS Mood). Depending on the underlying distribution of the variables analyzed, parametric (t-tests) or nonparametric tests (U-tests) were performed to compare mean values and distributions both within and between the treatment groups.

Results: The final examination revealed a statistically significant difference between the two groups for the VAS mental health and quality of life, as also for SIS Mood at the telephone interview in week 2. A comparison of baseline with the final examination within the groups showed a statistically significant improvement in the EGb 761 group for the variables: depression, fatigue, anger and SDS. For none of the variables investigated was a worsening observed in the EGb 761 group.

Conclusions: The results suggest a positive effect of EGb 761 on the subjective emotional well-being of healthy elderly persons.

[银杏叶对健康老年人的影响]。
背景与目的:在过去的25年里,大量研究证实了银杏提取物EGb 761对血管发生性认知障碍和阿尔茨海默型痴呆患者的心理能力和情绪健康的积极作用。本研究旨在探讨银杏专用提取物EGb 761对健康老年人主观情绪幸福感的短期影响。研究人群与方法:本研究设计为随机双盲、单中心、平行组研究。该研究包括66名年龄在50至65岁之间、没有与年龄相关的认知障碍的健康男女受试者。在4周的时间里,34名受试者每天服用240毫克EGb 761, 32名受试者服用安慰剂。在开始用药前和治疗28天后,受试者完成以下量表和问卷来确定主观情绪幸福感:心境状态量表(POMS)、抑郁自评量表(SDS)、生活质量评定量表(VAS-QoL)、一般健康量表(VAS-GH)和精神健康量表(VAS-MH),以及评估一般主观幸福感变化的新工具主观强度评分心境量表(SIS Mood)。根据所分析变量的基本分布,进行参数检验(t检验)或非参数检验(u检验)来比较治疗组内和治疗组之间的平均值和分布。结果:期末检查显示两组在VAS心理健康和生活质量方面有统计学差异,在第2周的电话访谈中,SIS情绪也有统计学差异。基线与组内期末考试的比较显示,EGb 761组在变量:抑郁、疲劳、愤怒和SDS方面有统计学显著改善。因为在EGb 761组中没有观察到任何变量的恶化。结论:egb761对健康老年人主观情绪幸福感有正向影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信